All studies except 1 reported clinical improvements in skin lesions following RTX plus IVIG therapy; the exception was a case report involving paraneoplastic pemphigus. The combination therapy was ...

The following is a summary of “Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review ...

Combination rituximab and IVIG therapy may be a viable treatment option for patients with refractory autoimmune diseases, though the quality of evidence is low.

A multidisciplinary, multi-organizational panel of experts in medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, urology ...

In this article, we reviewed the current state of knowledge concerning the treatment of pemphigus. There is accumulating evidence for the efficacy for various treatment modalities. We began to use ...

Erythema migrans and erythema multiforme both cause target- or bull’s-eye-shaped lesions. Erythema migrans is due to Lyme disease. Erythema multiforme is an immune-mediated hypersensitivity skin ...

Paraneoplastic syndromes are rare cancer-related disorders in which symptoms are caused by the body’s immune response to the tumor or by substances the tumor secretes, such as autoantibodies, ...

The acronym PEMPHIGUS is suggested to encompass the numerous factors involved in the pathogenesis and course of the disease. In the following review the authors present studies documenting these ...